⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 19, 2024Open Access

A case of COVID-19-associated C-ANCA vasculitis was successfully treated with Rituximab therapy.

Michael R. Filoramo Renish N Contractor Deepak Chandramohan Prabhat Singh Nihar Jena Prathap Simhadri

View Full Paper

Ask AI

Bookmark

Share

Abstract

a-case-of-covid-19-associated-c-anca-vasculitis-was-successfullytreated-with-rituximab-therapy Hosted file COVID ANCA Vasculitis renal biopsy image .docxavailable at https:

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Filoramo et al. (2024) studied this question.

synapsesocial.com/papers/68e5bc3fb6db64358755483d https://doi.org/10.22541/au.172405783.30148293/v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A case of <scp>COVID</scp>‐19‐associated C‐<scp>ANCA</scp> vasculitis, was successfully treated with rituximab therapy2024
2Case Report: Dual immunomodulatory and hematologic benefits of rituximab in refractory anemia of ANCA-associated vasculitis2025
3Rituximab therapy in severe PR3-ANCA pulmonary–renal syndrome: A clinical and pharmaceutical case reportCase Report · 2026
4Complex Challenges in ANCA-Associated Vasculitis: A Case of COVID-19, Cytomegalovirus Pneumonitis, and Hemorrhagic Cholecystitis Following Rituximab TherapyOriginal Research · 2026
5Plasma exchange combined with low-dose rituximab treatment: A case report of severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis in the elderly2025